The Prosus and Benesse-backed online skills learning marketplace priced its shares at the top of their range to raise approximately $421m.

The Merck & Co and Roche-backed Duchenne muscular dystrophy drug developer has gone public in an upsized IPO sized at approximately $182m.

Henry Crown and Company achieved an exit as the root canal technology developer listed on the New York Stock Exchange below its IPO range.

Chiesi, Lundbeck and Li-Cor Biosciences scored exits as the oncology therapy developer floated in an upsized $75.6m initial public offering.

Advance Publications and American Express scored exits as the fashion subscription service floated at the top of its range in an upsized offering.

AES and Siemens' energy storage venture, which also counts Qatar Investment Authority as an investor, priced the offering above its range.

The Tencent and Berkshire Hathaway-backed digital bank, valued at $30bn in June, has confidentially filed to go public on the New York Stock Exchange.

Takeda, Merck & Co, Ipsen and Merck Group all scored exits as the immuno-oncology drug developer floated at the bottom of its IPO range.

The market communicationns platform developer is going public today in an $81m initial public offering which will enable OpenText to exit.

AstraZeneca, Eli Lilly and Sinopharm all achieved exits as the cancer therapy developer listed on the Hong Kong Stock Exchange at a reported valuation of nearly $1.1bn.